Neximerican 20mg Delayed Release 14 Capsule

Active Ingredient: Esomeprazole Oral: Esomeprazole magnesium and esomeprazole strontium: Gastroesophageal reflux disease (Rx only): Healing of erosive esophagitis: Short-term (4 to 8 weeks) treatment of erosive esophagitis Maintenance of healing of erosive esophagitis: Maintaining symptom resolution and healing of erosive esophagitis Symptomatic gastroesophageal reflux disease: Short-term (4 to 8 weeks) treatment of symptomatic gastroesophageal reflux disease (GERD) Helicobacter pylori eradication (Rx only): As part of a multidrug regimen for Helicobacter pylori eradication in patients with duodenal ulcer disease (active or history of within the past 5 years) Risk reduction of nonsteroidal anti-inflammatory drug-associated gastric ulcer (Rx only): Prevention of gastric ulcers associated with continuous NSAID therapy in patients at risk (age ≥60 years and/or history of gastric ulcer) Pathological hypersecretory conditions, including Zollinger-Ellison syndrome (Rx only): Treatment (long-term) of pathological hypersecretory conditions including Zollinger-Ellison syndrome Esomeprazole magnesium: Heartburn (OTC labeling): Treatment of frequent heartburn (≥2 days per week). IV: Esomeprazole sodium: Gastroesophageal reflux disease (Rx only): Short-term (≤10 days) treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis in pediatric patients 1 month to 17 years of age and adults when oral therapy is not possible or appropriate Risk reduction of ulcer rebleeding postprocedure (Rx only): Decrease the risk of rebleeding postendoscopy for acute bleeding gastric or duodenal ulcers in adults